Glycomine (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $115,000,000
Company Info
- Company Description
- Glycomine is focused on developing therapies for rare genetic disorders, leveraging innovative approaches to address unmet medical needs.
- Market
- Rare genetic disorders